Company intelligence / Profile preview
Hyundai Pharmaceutical Co., Ltd.
Cheonan-si, Chungcheongnam-do, South Koreamarketscreener.com ↗
- Ownership
- Private
- Employees
- ~393
- Development stage
- Commercial
01
Overview
Hyundai Pharmaceutical has a long-standing presence in the Korean pharmaceutical market with commercialized generic drugs and health food products. The company also invests in new drug development targeting chronic diseases prevalent in aging populations such as hypertension and dementia. It has received regulatory approvals for clinical trials of new medicines like HD-003 (new medicine) and HFT-401 (arthritis), collaborates with academic institutions for technology transfer/new molecule development (e.g., Yonsei University), and maintains an active R&D pipeline focused on both incremental innovation/improved formulations as well as novel therapeutics
- Therapeutic areas
- EndocrinologyImmunologyHematologyPsychiatryDermatologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Primarily small moleculesgenericsimproved dosage forms
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
Request access →03
Partnerships
Bausch & Lomb – co-promotion agreement for Ocuvite eye productOphtecs Corp Japan – license-in agreement for Ruping eye drop/artificial tear productForhumantech – co-development of arthritis medicine HFT–401Yonsei University – technology transfer/new anti-obesity molecule collaboration
Beyond the preview
Go deeper on Hyundai Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hyundai Pharmaceutical Co., Ltd..